Lista de obras - Stefania Scala - Dominio Público Uruguay

"CXCR4-CXCL12 and VEGF correlate to uveal melanoma progression".

artículo científico publicado en 2010

A novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumors

artículo científico publicado en 2017

A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion

artículo científico publicado en 2015

A point mutation (G574A) in the chemokine receptor CXCR4 detected in human cancer cells enhances migration

artículo científico publicado en 2009

A possible predictive marker of progression for hepatocellular carcinoma

artículo científico publicado en 2011

A prognostic model comprising pT stage, N status, and the chemokine receptors CXCR4 and CXCR7 powerfully predicts outcome in neoadjuvant resistant rectal cancer patients

artículo científico publicado en 2014

Accreditation for excellence of cancer research institutes: recommendations from the Italian Network of Comprehensive Cancer Centers

artículo científico publicado en 2013

Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias

artículo científico publicado en 2000

Adjuvant treatment of malignant melanoma: where are we?

artículo científico publicado en 2005

Alpha 2b interferon (IFN) by intraperitoneal administration via temporary catheter in ovarian cancer. Preliminary data.

artículo científico publicado en 1991

Bevacizumab increases viral distribution in human anaplastic thyroid carcinoma xenografts and enhances the effects of E1A-defective adenovirus dl922-947.

artículo científico publicado en 2008

Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity

artículo científico publicado en 1996

CD4(+)CD45RA(+)CXCR4 (+) lymphocytes are inversely associated with progression in stages I-III melanoma patients.

artículo científico publicado en 2009

COX-2 expression positively correlates with PD-L1 expression in human melanoma cells

artículo científico publicado en 2017

CXC chemokine receptor 4 is expressed in uveal malignant melanoma and correlates with the epithelioid-mixed cell type

artículo científico publicado en 2007

CXCL12-binding receptors expression in non-small cell lung cancer relates to tumoral microvascular density and CXCR4 positive circulating tumoral cells in lung draining venous blood

artículo científico publicado en 2011

CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells

artículo científico publicado en 2014

CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not

artículo científico publicado en 2014

CXCR4-antagonist Peptide R-liposomes for combined therapy against lung metastasis.

artículo científico publicado en 2016

CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR.

artículo científico publicado en 2016

Cell surface expression of major histocompatibility class I antigens is modulated by P-glycoprotein transporter

artículo científico publicado en 1995

Cellular and biophysical evidence for interactions between adenosine triphosphate and P-glycoprotein substrates: functional implications for adenosine triphosphate/drug cotransport in P-glycoprotein overexpressing tumor cells and in P-glycoprotein l

artículo científico publicado en 2001

Cetuximab-dependent ADCC in cancer: dream or reality?

artículo científico publicado en 2010

Chemoresistance in the clinic: overview 1994.

artículo científico publicado en 1994

Coexpression of TGF alpha, epidermal growth factor receptor, and P-glycoprotein in normal and benign diseased breast tissues

artículo científico publicado en 1995

Concomitant CXCR4 and CXCR7 Expression Predicts Poor Prognosis in Renal Cancer

artículo científico publicado en 2010

Conformational ensembles explored dynamically from disordered peptides targeting chemokine receptor CXCR4.

artículo científico publicado en 2015

Cystic Fibrosis Transmembrane Conductance Regulator and Adenosine Triphosphate

artículo científico publicado en 1997

Detection, monitoring, and management of trastuzumab-induced left ventricular dysfunction: an actual challenge.

artículo científico

Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy

artículo científico publicado en 2016

Differential role of CD133 and CXCR4 in renal cell carcinoma

artículo científico publicado en 2010

Effect of thymic extract 'thymostimulin' on the incidence of infections and myelotoxicity during adjuvant chemotherapy for breast cancer.

artículo científico publicado en 1988

Engineering of thermoresponsive gels as a fake metastatic niche

artículo científico publicado en 2018

Epigenome-wide association study in hepatocellular carcinoma: Identification of stochastic epigenetic mutations through an innovative statistical approach.

artículo científico publicado en 2017

Epithelial-to-mesenchymal transition in FHC-silenced cells: the role of CXCR4/CXCL12 axis.

artículo científico

Everolimus and pancreatic neuroendocrine tumors (PNETs): Activity, resistance and how to overcome it.

artículo científico

Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer

artículo científico publicado en 2020

Exploring the N-Terminal Region of C-X-C Motif Chemokine 12 (CXCL12): Identification of Plasma-Stable Cyclic Peptides As Novel, Potent C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonists

artículo científico publicado en 2016

Expression of CXCR4 Predicts Poor Prognosis in Patients with Malignant Melanoma

artículo científico publicado en 2005

Fc gamma receptor IIIa polymorphisms in advanced colorectal cancer patients correlated with response to anti-EGFR antibodies and clinical outcome.

artículo científico publicado en 2012

HCV-related hepatocellular carcinoma: From chronic inflammation to cancer

artículo científico publicado en 2009

HMGI-C gene expression is not required for in vivo thyroid cell transformation

artículo científico publicado en 2001

High CXCR4 expression correlates with sunitinib poor response in metastatic renal cancer.

artículo científico publicado en 2012

Histomorphologic parameters and CXCR4 mRNA and protein expression in sentinel node melanoma metastasis are correlated to clinical outcome

scientific article published on 20 March 2010

Human melanoma metastases express functional CXCR4.

artículo científico publicado en 2006

IRF-8 controls melanoma progression by regulating the cross talk between cancer and immune cells within the tumor microenvironment.

artículo científico publicado en 2012

Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer

artículo científico publicado en 2015

In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies

artículo científico publicado en 2022

Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo

artículo científico publicado en 1998

Inhibition of Sp1 activity by a decoy PNA-DNA chimera prevents urokinase receptor expression and migration of breast cancer cells

artículo científico publicado en 2005

Inhibition of stromal CXCR4 impairs development of lung metastases.

artículo científico publicado en 2012

Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells

scientific article published on 11 December 2004

Interaction between HMGA1 and retinoblastoma protein is required for adipocyte differentiation.

scientific article published on 26 July 2009

Interaction between HMGA1 and retinoblastoma protein is required for adipocyte differentiation.

artículo científico publicado en 2014

Intrinsically disordered amphiphilic peptides as potential targets in drug delivery vehicles

artículo científico publicado en 2015

Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)-Ligand Interactions on Living Cancer Cells.

artículo científico publicado en 2018

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

artículo científico publicado en 2016

Modulation of chemosensitivity by alpha interferon in multiple myeloma and non-Hodgkin's lymphoma

artículo científico publicado en 1996

Molecular Pathways: Targeting the CXCR4-CXCL12 Axis--Untapped Potential in the Tumor Microenvironment

artículo científico

Natural killer cells activity in a metastatic colorectal cancer patient with complete and long lasting response to therapy.

artículo científico publicado en 2017

New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer

scientific article published on 18 July 2020

New Insights on the Emerging Genomic Landscape of CXCR4 in Cancer: A Lesson from WHIM

scientific article published on 03 April 2020

Novel mutation of the PTEN gene in an Italian Cowden's disease kindred

article

ONYX-015, an E1B gene-defective adenovirus, induces cell death in human anaplastic thyroid carcinoma cell lines

article

Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients

artículo científico publicado en 2006

P01.16MICROGLIA/MACROPHAGES AS CELLULAR TARGET OF NOVEL CXCR4 ANTAGONIST IN A GLIOMA MODEL.

artículo científico publicado en 2014

Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies

artículo científico publicado en 2005

Peptides targeting chemokine receptor CXCR4: structural behavior and biological binding studies

scientific article published on 28 January 2014

Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial

artículo científico publicado en 2016

Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastases

artículo científico publicado en 2013

Prediction of response to anti-EGFR antibodies in metastatic colorectal cancer: looking beyond EGFR inhibition

artículo científico publicado en 2012

Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.

artículo científico publicado en 2015

Prognostic value of serum VEGF in melanoma patients: a pilot study

artículo científico publicado en 2004

Prospective Evaluation of Cetuximab-Mediated Antibody-Dependent Cell Cytotoxicity in Metastatic Colorectal Cancer Patients Predicts Treatment Efficacy

artículo científico publicado en 2016

Prostate cancer detection in the "grey area" of prostate-specific antigen below 10 ng/ml: head-to-head comparison of the updated PCPT calculator and Chun's nomogram, two risk estimators incorporating prostate cancer antigen 3.

artículo científico publicado en 2010

RETRACTED: Critical role of the HMGI(Y) proteins in adipocytic cell growth and differentiation

artículo científico publicado en 2001

Radiation therapy following surgery for localized breast cancer: outcome prediction by classical prognostic factors and approximated genetic subtypes

artículo científico publicado en 2012

Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression

artículo científico publicado en 1997

Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma

artículo científico publicado en 2013

Resistance to paclitaxel mediated by P-glycoprotein can be modulated by changes in the schedule of administration

artículo científico publicado en 1997

Reversal of Multidrug Resistance

artículo científico publicado en 1994

Reversal of adriamycin resistance by recombinant alpha-interferon in multidrug-resistant human colon carcinoma LoVo-doxorubicin cells

artículo científico publicado en 1991

Reversal of multidrug resistance.

artículo científico publicado en 1994

Serum cytokine levels in patients with hepatocellular carcinoma

artículo científico publicado en 2010

Soluble interleukin-2 receptor in stage I–III melanoma

scientific article published on 01 February 2006

Structure-Activity Relationships and Biological Characterization of a Novel, Potent, and Serum Stable C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonist

artículo científico publicado en 2017

Study of Ras Mutations' Prognostic Value in Metastatic Colorectal Cancer: STORIA Analysis

scientific article published on 16 July 2020

Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model

artículo científico publicado en 2016

Targeting CXCR4 reverts the suppressive activity of T-regulatory cells in renal cancer.

artículo científico publicado en 2017

Targeting the inflammation in HCV-associated hepatocellular carcinoma: a role in the prevention and treatment ⬇️

artículo científico publicado el 3 de noviembre de 2010

Temozolomide and cisplatin in avdanced malignant melanoma.

artículo científico publicado en 2005

The N-terminal region of CXCL11 as structural template for CXCR3 molecular recognition: synthesis, conformational analysis, and binding studies

artículo científico publicado en 2012

Tissue Micro Arrays for immunohistochemical detection of inflammatory infiltrates in renal cell carcinoma

artículo científico publicado en 2014

Tissue micro arrays for immunohistochemical detection of inflammatory infiltrates in renal cell carcinoma

artículo científico publicado en 2014

Truncated and chimeric HMGI-C genes induce neoplastic transformation of NIH3T3 murine fibroblasts

artículo científico publicado en 1998

Tumour biomarkers: homeostasis as a novel prognostic indicator

artículo científico publicado en 2016

Variability in Immunohistochemical Detection of Programmed Death Ligand 1 (PD-L1) in Cancer Tissue Types.

artículo científico publicado en 2016

Lista de obras de Stefania Scala

"CXCR4-CXCL12 and VEGF correlate to uveal melanoma progression".

A novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumors

A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion

A point mutation (G574A) in the chemokine receptor CXCR4 detected in human cancer cells enhances migration

A possible predictive marker of progression for hepatocellular carcinoma

A prognostic model comprising pT stage, N status, and the chemokine receptors CXCR4 and CXCR7 powerfully predicts outcome in neoadjuvant resistant rectal cancer patients

Accreditation for excellence of cancer research institutes: recommendations from the Italian Network of Comprehensive Cancer Centers

Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias

Adjuvant treatment of malignant melanoma: where are we?

Alpha 2b interferon (IFN) by intraperitoneal administration via temporary catheter in ovarian cancer. Preliminary data.

Bevacizumab increases viral distribution in human anaplastic thyroid carcinoma xenografts and enhances the effects of E1A-defective adenovirus dl922-947.

Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity

CD4(+)CD45RA(+)CXCR4 (+) lymphocytes are inversely associated with progression in stages I-III melanoma patients.

COX-2 expression positively correlates with PD-L1 expression in human melanoma cells

CXC chemokine receptor 4 is expressed in uveal malignant melanoma and correlates with the epithelioid-mixed cell type

CXCL12-binding receptors expression in non-small cell lung cancer relates to tumoral microvascular density and CXCR4 positive circulating tumoral cells in lung draining venous blood

CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells

CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not

CXCR4-antagonist Peptide R-liposomes for combined therapy against lung metastasis.

CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR.

Cell surface expression of major histocompatibility class I antigens is modulated by P-glycoprotein transporter

Cellular and biophysical evidence for interactions between adenosine triphosphate and P-glycoprotein substrates: functional implications for adenosine triphosphate/drug cotransport in P-glycoprotein overexpressing tumor cells and in P-glycoprotein l

Cetuximab-dependent ADCC in cancer: dream or reality?

Chemoresistance in the clinic: overview 1994.

Coexpression of TGF alpha, epidermal growth factor receptor, and P-glycoprotein in normal and benign diseased breast tissues

Concomitant CXCR4 and CXCR7 Expression Predicts Poor Prognosis in Renal Cancer

Conformational ensembles explored dynamically from disordered peptides targeting chemokine receptor CXCR4.

Cystic Fibrosis Transmembrane Conductance Regulator and Adenosine Triphosphate

Detection, monitoring, and management of trastuzumab-induced left ventricular dysfunction: an actual challenge.

Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy

Differential role of CD133 and CXCR4 in renal cell carcinoma

Effect of thymic extract 'thymostimulin' on the incidence of infections and myelotoxicity during adjuvant chemotherapy for breast cancer.

Engineering of thermoresponsive gels as a fake metastatic niche

Epigenome-wide association study in hepatocellular carcinoma: Identification of stochastic epigenetic mutations through an innovative statistical approach.

Epithelial-to-mesenchymal transition in FHC-silenced cells: the role of CXCR4/CXCL12 axis.

Everolimus and pancreatic neuroendocrine tumors (PNETs): Activity, resistance and how to overcome it.

Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer

Exploring the N-Terminal Region of C-X-C Motif Chemokine 12 (CXCL12): Identification of Plasma-Stable Cyclic Peptides As Novel, Potent C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonists

Expression of CXCR4 Predicts Poor Prognosis in Patients with Malignant Melanoma

Fc gamma receptor IIIa polymorphisms in advanced colorectal cancer patients correlated with response to anti-EGFR antibodies and clinical outcome.

HCV-related hepatocellular carcinoma: From chronic inflammation to cancer

HMGI-C gene expression is not required for in vivo thyroid cell transformation

High CXCR4 expression correlates with sunitinib poor response in metastatic renal cancer.

Histomorphologic parameters and CXCR4 mRNA and protein expression in sentinel node melanoma metastasis are correlated to clinical outcome

Human melanoma metastases express functional CXCR4.

IRF-8 controls melanoma progression by regulating the cross talk between cancer and immune cells within the tumor microenvironment.

Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer

In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies

Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo

Inhibition of Sp1 activity by a decoy PNA-DNA chimera prevents urokinase receptor expression and migration of breast cancer cells

Inhibition of stromal CXCR4 impairs development of lung metastases.

Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells

Interaction between HMGA1 and retinoblastoma protein is required for adipocyte differentiation.

Interaction between HMGA1 and retinoblastoma protein is required for adipocyte differentiation.

Intrinsically disordered amphiphilic peptides as potential targets in drug delivery vehicles

Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)-Ligand Interactions on Living Cancer Cells.

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

Modulation of chemosensitivity by alpha interferon in multiple myeloma and non-Hodgkin's lymphoma

Molecular Pathways: Targeting the CXCR4-CXCL12 Axis--Untapped Potential in the Tumor Microenvironment

Natural killer cells activity in a metastatic colorectal cancer patient with complete and long lasting response to therapy.

New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer

New Insights on the Emerging Genomic Landscape of CXCR4 in Cancer: A Lesson from WHIM

Novel mutation of the PTEN gene in an Italian Cowden's disease kindred

ONYX-015, an E1B gene-defective adenovirus, induces cell death in human anaplastic thyroid carcinoma cell lines

Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients

P01.16MICROGLIA/MACROPHAGES AS CELLULAR TARGET OF NOVEL CXCR4 ANTAGONIST IN A GLIOMA MODEL.

Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies

Peptides targeting chemokine receptor CXCR4: structural behavior and biological binding studies

Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial

Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastases

Prediction of response to anti-EGFR antibodies in metastatic colorectal cancer: looking beyond EGFR inhibition

Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.

Prognostic value of serum VEGF in melanoma patients: a pilot study

Prospective Evaluation of Cetuximab-Mediated Antibody-Dependent Cell Cytotoxicity in Metastatic Colorectal Cancer Patients Predicts Treatment Efficacy

Prostate cancer detection in the "grey area" of prostate-specific antigen below 10 ng/ml: head-to-head comparison of the updated PCPT calculator and Chun's nomogram, two risk estimators incorporating prostate cancer antigen 3.

RETRACTED: Critical role of the HMGI(Y) proteins in adipocytic cell growth and differentiation

Radiation therapy following surgery for localized breast cancer: outcome prediction by classical prognostic factors and approximated genetic subtypes

Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression

Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma